Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MacLeod

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
Nature Medicine|March 22, 2024
Understanding the provenance and quality of methods is essential for responsible reuse of FAIR dataTracey L Weissgerber, Małgorzata Anna Gazda, Gustav Nilsonne, et al.
Plos Biology|October 14, 2015
Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
European Stroke Journal|September 25, 2018
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessmentHendrik Reinink, Jeroen C de Jonge, Philip M Bath, et al.
F1000Research|March 26, 2019
Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysisManoj M Lalu, Dean A Fergusson, Wei Cheng, et al.
Wellcome Open Research|April 18, 2024
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studiesSpyridon Siafis, Robert McCutcheon, Virginia Chiocchia, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Plos One|January 12, 2018
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studiesCarlijn R Hooijmans, Rob B M de Vries, Merel Ritskes-Hoitinga, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
Nature Medicine|March 22, 2024
Understanding the provenance and quality of methods is essential for responsible reuse of FAIR dataTracey L Weissgerber, Małgorzata Anna Gazda, Gustav Nilsonne, et al.
Plos Biology|October 14, 2015
Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
European Stroke Journal|September 25, 2018
PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessmentHendrik Reinink, Jeroen C de Jonge, Philip M Bath, et al.
F1000Research|March 26, 2019
Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysisManoj M Lalu, Dean A Fergusson, Wei Cheng, et al.
Wellcome Open Research|April 18, 2024
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studiesSpyridon Siafis, Robert McCutcheon, Virginia Chiocchia, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Plos One|January 12, 2018
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studiesCarlijn R Hooijmans, Rob B M de Vries, Merel Ritskes-Hoitinga, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Pageof 32